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A 39-Year Follow-up of the U.K. Oil Refinery
and Distribution Center Studies: Results for
Kidney Cancer and Leukemia
by Lesley Rushton
This paper presents briefly some of the principal results of a mortality analysis of a cohort of workers
employed for at least 1 year between 1950 and 1975 at eight oil refineries and approximately 750 distribution
centersintheU.K,togetherwithdetailedresultsforkidneycancerandleukemia.Over99%oftheworkerswere
successfully traced. Their mortality was compared with that of all males in the national population. The
mortalityfromallcausesofdeathislowerthanthatofthecomparisonpopulation inbothstudies, andreduced
mortality is also found for many of the major nonmalignant causes of death. In the refinery study, some
increasedmortalitypatternsarefoundfordiseases ofthe arteries, andnohealthyworkereffect isfound inthe
distribution center study for ischemic heart disease. Mortality from all neoplasms is lower than expected
overall inbothstudies, largelydueto adeficit ofdeaths from malignantneoplasm ofthe lung. Mortality from
malignant neoplasm of the kidney is increased overall in the distribution center study, and in drivers in
particular. The mortality from this disease increases with increased time since first exposure. The observed
deaths from leukemia are slightly less than expected in the refinery study and slightly more than expected in
the distribution center study. One refinery shows increased mortality due to in myeloid leukemia, and
mortality is increased among refinery operators. Mortality is also raised in distribution center drivers,
particularly for myeloid leukemias, including acute myeloid leukemia.
Introduction
The aim ofthe Institute ofPetroleum (IP) Epidemiolo-
gical Study was to examine patterns of mortality of
employees in oilrefineries and distribution centers, taking
into account such factors as age and type of occupation.
The initial study followed up the employees from 1951 to
1975. This paper describes briefly some of the principal
findings from an extension of this follow-up to 1989 and
gives detailed information on the leukemia and kidney
cancer findings.
Review ofthe Literature
Many early studies have documented the carcinogenic
properties ofoilboth inexperimental studies (1-5) andthe
occupational field (6-8). Conflicting results have been
reported on oil mist exposure, in particular, its effect on
lung cancer (9-11). Over 70 papers and unpublished
reports document past or on-going studies of the mor-
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tality and, less often, the morbidity, of refinery popula-
tions.Althoughthereisconsiderablevariationinthedates,
length of follow-up period and numbers in the studies,
most of them find low overall mortality, which is also
reflected in many of the nonmalignant disease groups.
Most of the papers focus on malignant disease with
increased mortality patterns being found for several
malignant disease groups, although with much variation
between the studies. A detailed review ofthese is given in
the report of the principal results of the Institute of
Petroleum (IP) refinery study (12,13). Fourpapers (14-17)
also provide narrative epidemiological reviews of studies
ofoil refinery workers.
There have been relatively few studies ofworkers at oil
distribution centers, although they have been included in
some broader studies ofthe oil industry (18-20). Harring-
ton (14) reviews both thepetroleummanufacturing indus-
try and the distribution industry with regard to all
diseases.
Considerable interest has been shown in the effect of
gasoline exposure onthekidneys (21). In apapergiven at a
1983 workshop, Phillips (22) reviewed six case-control
studies,five(23-27) ofwhich showed apositiveassociation
between hydrocarbon exposure and glomerulonephritis,
although he pointed out several methodological weak-
nesses in these studies.
Particular attention has been focused on leukemia (and
other diseases of the haematopoietic system) and kidneyL. RUSHTON
cancer. The association between exposure to benzene and
leukemia has been discussed in many studies of popula-
tions outside the oil industry (28-30) and increases in
mortality have been found in several oil refinery popula-
tions (31-34). Nonsignificant excesseswerefoundinblend-
ing and packaging plant workers (35) and among
producing and pipeline workers (36). Christie (37)
reported a significantly increased incidence of leukemia,
especiallymyeloidleukemia, comparedwithratesobtained
from cancer registries.
Although animal studies have shown some association
between hydrocarbon exposure and kidney cancer (38,39),
an extensive review ofthis problem in humans at a work-
shop in 1983 failed to come to any firm conclusion. Gener-
ally, anyexcesses are small (40-42) orshowno association
(21,43,44).
Afewstudies ofresidentpopulations in areaswherethe
petroleum industry is concentrated have suggested links
between certain diseases and thepetroleumindustry (45-
49). However, as Harrington (14)points out, thesetypes of
studies are, at best, hypothesis-generating exercises, and
should therefore be interpreted with caution.
Several studies have carried out personal air sampling
or taken urine samples to investigate the exposure to
benzene ofworkers atbulkmarketingterminals (50,51) or
service stations (52-56). A proportional mortality study
study (57) of all deaths over a 10-year period in New
Hampshire found high proportional mortality ratios
(PMRs) for service station workers for leukemia, suicide,
emphysema, and mental conditions. De Silva (58) mea-
sured blood lead levels of gasoline pump attendants in
Melbourne and concluded that the levels were lower than
the acceptedlevel ofconcern. Other studies have looked at
the effect ofdiesel exhaust emissions (59,60).
EarlierReportsoftheInstituteofPetroleumStudies.
Theoverallmortalityinthepreviouslyreportedresultsfor
the follow-up to 1975 (61,62) was considerably lower than
expected inboth the IPstudies, aswas themortalityfrom
stroke, bronchitis, andpneumonia. Heartdiseasewas also
low in the refinery study, but there was no evidence of a
healthy worker effect for ischemic heart disease in the
distribution center study. The lowered mortality from all
neoplasms in both studies was due to a large deficit of
observed deaths from lung cancer. Increased mortality
patterns were found in several refineries for malignant
neoplasms ofthe esophagus, stomach, intestines, and rec-
tum, with significantly more deaths than expected from
malignant neoplasms of the nasal cavities and sinus and
from melanoma. Mortality from myelofibrosis and dis-
eases of the lymphatic and haematopoietic tissue was
slightly raised overall in the distribution center study.
Methods
Full details of the feasibility study carried out before
the initial data collection, the reasoning behind the choice
of data items to be collected, and the analysis methods
used are given elsewhere (61,62). Briefly, the study
includes all men with a length of service of at least 1
continuous year between Janurary 1, 1950, and December
31,1975 ateightrefineries andapproximately750distribu-
tion centers in the U.K. In this paper the refineries are
denoted by A,B,C,D,F,G,H, and J, and the distribution
center study companies by 1, 2, and 3.
Detailedinformation ondatacollected,tracingandflag-
ging procedures, data validation, comparison populations,
and calculation of expected deaths is reported elsewhere
(12,13,63,64). Briefly, identification data, dates of employ-
ment, lastjob (or presentjob for those in employment on
Janurary1,1976), and National Health Service (NHS) and
National Insurance (NI) numbers, where available, were
collected for each study member.
Inthesecondfollow-upfrom1976to1989,reportedhere,
dataforallthe studypopulationstill alive onDecember31,
1975 were sent to the National Health Service Central
Register (NHSCR), which identified those subjects who
had since died and provided the death certificates. The
records for all the otherswere thenflagged. This flagging
procedureenablestheNHSCRtoidentifythe studypopula-
tion who die in the future and to provide the death details.
Thiscontrastswiththefirstfollow-upinwhichno attemptat
long-term collection ofdeath certificates was made.
The death certificates provide multiple causes ofdeath
coded to the relevant International Classification of Dis-
ease (ICD)revision. The causesweregrouped foranalysis
into the ICD "A" list. Thosewho emigrated were assumed
to be alive up to the date ofemigration, and this date was
therefore their study-end date.
As in the analysis of the first follow-up (61,62), the
expected deaths were calculated by applying the age- and
calendar-period-specific standard death rates to the five-
year age- and calendar-period person-years at risk in the
study cohort. In the refinery study, the England and
Wales rates were used for the six English orWelsh refin-
eries and corresponding Scottish rates for the two Scot-
tish refineries. As the distribution centers are well-
scattered throughout the U.K., it was decided, as before,
nottoanalyzethedatainScotlandand10standardregions
inEnglandandWales separately, asthenumberswouldbe
reduced too much for analysis. The rates for England and
Wales were thus used in this study.
The standardized mortality ratio (SMR) is calculated
fromtheratio ofobserveddeaths overtheexpected deaths
multiplied by 100. The 95% confidence interval also has
been given for each SMR (19). No formal adjustment has
been made to take account of known regional or social
classvariations in deathrates, butthesehavebeenused to
aid the interpretation ofthe results.
Two approaches to the analyses were used, as in the
previouslyreported papers (61,65).The firstapproach, the
a posteriori approach, involved examination of the pat-
terns and magnitude ofmortality using the SMR and its




Table 1 showsthestatusofthetotalstudypopulations on
December 31, 1989. There are 34,569 men in the refineryUK OIL INDUSTRY KIDNEY CANCER, AND LEUKEMIA
lable 1. Vital status ofthe study populations on December 31,1989.
Status Refinery study (%) Distribution study (%)
Alive 22,600 (65) 14,168 (61)
Dead 10,193 (30) 8,743 (38)
Emigrated 1,691 (5) 297 (1)
No trace 85 (0.25) 98 (0.42)
Total 34,569 (100) 23,306 (100)
study(comparedwith34,781 on December31,1975),22,600
alive, 10,193 dead, 1,691 emigrated, and85untraced. There
are 23,306 men in the distribution center study, 14,168
alive, 8,743 dead, 297 emigrated, and 98 untraced. As
before, untraced subjects were not included in the analy-
ses. Included in the alive groups are 1004 men in the
refinery study and 723 in the distribution center study
whom it was not possible to flag at the NHSCR but who
have been traced as alive on December 31, 1989, through
the National Insurance records. Those dead include 70 in
the refinery study and 66 in the distribution center study
for whom it was not possible to obtain a death certificate.
In the analyses, all these records are taken as dead, cause
unknown. The person-years ofobservation has increased
in the second follow-up by 62% to approximately 93,000 in
therefinerystudyandby58% to approximately 625,000in
the distribution center.
Mortality Results
The general results from both studies are first
described briefly [full details are given elsewhere
(12,13,63,64)], followed by a report of the findings for
kidney cancer and leukemia. Table 2 gives the observed
and expected deaths, the SMR, and the 95% confidence
interval for the SMR for all causes of death and all
neoplasms for the total refinery and distribution center
populations; separatelyforthe firstfollow-upperiod, 1951-
1975; the second follow-up period, 1976-1989; andthetotal
follow-up period, 1951-1989.
The SMRsfor all causes are approximatelythe samefor
the two follow-up periods in the refinery study. In the
distribution centerstudy, the SMR inthe second follow-up
period is higher than in the first but still markedly low,
showing a continuation ofthe healthyworkereffect. There
is a tendency forthe all-cause mortalityin both studies to
increase with increasing time since first exposure and
earlieryearofstartingwork.The SMRsforthetwofollow-
up periods for all neoplasms in the refinery study are
identical. In the distribution center study, the mortality
from all neoplasms is markedly low in the first follow-up
period, but the observed deaths are only slightly less than
those expected in the second period.
Table 3 gives the observed and expected deaths, SMR,
and 95% confidence interval for selected nonmalignant
causes ofdeath, separately for the total populations ofthe
two studies. The low overall mortality is also reflected in
many ofthese diseases, such as cerebrovascular disease,
hypertensive heart disease, pneumonia, and bronchitis.
The mortality is generally low in the nonmalignant dis-
eases for all the job groups except a) laborers/general
manual workers in both studies, where it is raised in
several disease groups (e.g., cerebrovascular disease, dis-
eases ofthe arteries, and pneumonia); b) security men in
the distribution centerstudy, forwhommortalityis raised
by about 5%; and c) fire and safety workers, drivers, and
storemenintherefinerystudy,wherethe observed deaths
approximately equal those expected.
In the refinery study, the only large, nonmalignant
disease group to show consistently increased mortality
patterns across several refineries, age, and job groups is
diseases of the arteries. There is a marked trend for
increasingmortalitywithincreasingtime sincefirstexpo-
sure for this disease group. The healthy worker effect in
the distribution center study is not reflected in ischemic
heart disease. Increased mortality is found in operators,
general manual workers, and clerical, administrative, and
managerial staffincompany2. The SMRs areparticularly
high for men between 45 and 55 years old at death and for
those between 60 and 70 years old. Mortality increases
withincreasingcalendarperiod offollow-upuntil1975and
then declines.
Table 4 gives the observed and expected deaths, SMR,
and its 95% confidence interval for selected malignant
neoplasms. The higher mortality in the second follow-up
period for all neoplasms in the distribution study is also
reflected in many of the individual groups of neoplasms,
whereas the opposite trend is generally found in the
refinery study. The low mortality from all neoplasms in
both studies is largely due to a deficit ofobserved deaths
frommalignantneoplasmofthelung,althoughthetrendis
forincreasingmortalityfrom this disease as the calendar
period of follow-up increases. Mortality is slightly
increased for malignant neoplasm of the lung for opera-
torsandgeneralmanualworkersinthedistribution center
study and is raised for riggers, storemen, and laborers in
the refinery study.
There are some increased mortality patterns in the
refinery study from malignant disease groups, for exam-
ple,frommalignantneoplasms ofthestomach,esophagus,
intestine, rectum, larynx, and prostate. These tend to be
more isolated results and are not consistent across the
refineries or job groups. The increased mortality from
melanoma found in the first follow-up period in this study
hasalsocontinuedinthesecondfollow-upperiod,although
to a slightly lesser extent, being increased in five of the
eight refineries and across severaljob groups. There are
also a few isolated increased mortality patterns in malig-
nant disease groups in the distribution center study,
namely,malignantneoplasmsoftheintestines,larynx, and
prostate, and other neoplasms of the lymphoid tissue.
Mortality is increased for operators from malignant neo-
plasm ofthe prostate in both studies.
Kidney Cancer. The observed deaths from malignant
neoplasm ofthe kidney in the refinery study are approx-
imately the same as those expected (Table 4). No raised
mortalitypatterns arefound in anysubgroupanalysesfor
this study.
Table 5 gives the observed and expected deaths, SMRs,
and 95% confidence intervals for malignant neoplasm of
thekidneyinthedistribution centerstudybycompanyand
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Table 2. Observed (0) and expected (E) deaths, standardized mortality ratio (SMR) and
95% confidence interval (CI) for all causes and all neoplasms.
Study Follow-up 1951-1975 Follow-up 1976-1989 Follow-up 1951-1989
0 E SMR 95% CI 0 E SMR 95% CI 0 E SMR 95% CI
All causes
Refinery 4,498 4,981.5 90 88-93 5,695 6,271.8 91 88-93 10,193 11,253.3 91 89-92
Distribution 3,964 4,547.1 87 84-90 4,779 5,052.9 95 92-97 8,743 9,600.0 91 89-93
All neoplasms
Refinery 1,163 1,234.6 94 89-100 1,610 1,715.2 94 89-99 2,773 2,949.8 94 91-98
Distribution 1,012 1,137.7 89 84-95 1,304 1,333.0 98 93-103 2,316 2,470.7 94 90-98
Table 3. Observed (0) and expected (E) deaths, standardized mortality ratio (SMR),
and 95% confidence intervals (CI) for nonmalignant causes ofdeath.
Refinery study Distribution study
Disease 0 E SMR 95% CI 0 E SMR 95% CI
Cerebrovascular disease 854 986.3 87 81-93 826 882.2 94 87-100
Ischemic heart disease 3367 3621.2 93 92-96 3037 3026.0 100 97-104
Other heart disease 230 270.5 85 74-97 207 254.9 81 71-93
Hypertensive heart disease 110 147.8 74 61-90 95 132.3 72 58-88
Diseases ofthe arteries 298 248.1 120 107-135 238 227.0 105 92-119
Pneumonia 391 450.4 87 78-96 376 445.3 84 76-93
Bronchitis 425 580.2 73 66-81 400 557.0 72 65-79
Motor vehicle accidents 142 154.5 92 77-108 100 99.6 100 82-122
Suicide 107 144.7 74 61-89 65 104.4 62 48-79
Table 4. Observed (0) and expected (E) deaths, standardized mortality ratio (SMR),
and 95% confidence intervals (CI) for malignant causes ofdeath.
Refinery study Distribution study
Malignant neoplasm of 0 E SMR 95% CI 0 E SMR 95% CI
Esophagus 104 92.5 112 92-136 50 74.5 67 50-89
Stomach 302 296.4 102 14-104 238 257.5 92 81-105
Intestine 186 190.3 98 84-113 160 160.1 100 85-117
Rectum 126 132.3 95 79-113 105 113.7 92 76-112
Liver + gall bladder 47 49.5 95 70-126 32 40.7 79 54-111
Pancreas 110 123.1 89 73-108 98 102.9 95 77-116
Larynx 26 28.2 92 60-135 33 24.0 138 95-193
Lung + pleura 1032 1166.3 88 83-94 873 977.4 89 83-95
Prostate 171 162.9 105 90-122 166 148.6 112 95-130
Bladder 98 110.4 89 72-108 84 97.4 86 69-107
Kidney 56 55.3 101 77-132 53 43.8 121 91-158
Brain 74 84.0 88 69-111 65 64.1 101 78-129
selected subgroups. Mortality is increased overall and, in
particular, at companies 2 and 3. The majority of the 53
kidney cancer deaths were coded to ICD 1890, malignant
neoplasm of the kidney except pelvis, with only 1 being
renal pelvis, 2 ureter, and 2 site unspecified. Mortality
from kidney cancer tends to decline as the year of entry
increases, with a corresponding increase with the time
since first exposure up to 30-39 years. Mortality is
increased in drivers, 15 of whom have 20 or more years
service. There are 11 other deaths where malignant neo-
plasm ofthe kidney is a contributory cause ofdeath (4 of
whom are drivers).
Leukemia. The mortality from leukemia is slightly
increased overall in the distribution center study and
slightly lower than expected in the refinery study, both
patternsbeingsimilarinthetwofollow-upperiods. Table6
gives the observed and expected deaths, SMRs, and 95%
confidence intervals for leukemia by type separately for
Table 5. Observed (0) and expected (E) deaths, standardized
mortality ratio (SMR), and 95% confidence intervals (CI) for
kidney cancer by company and selected subgroups.
0 E SMR 95% CI
Company 1 2 3.3 61 7-221
2 35 27.8 126 88-175
3 16 12.8 125 72-204
Total 53 43.8 121 91-158
Drivers, total 25 17.7 141 91-208
Years since first exposure
0-9 2 2.2 90 11-325
10-19 7 6.6 106 43-219
20-29 8 10.6 75 33-149
30-39 20 11.1 180 110-279
40-49 10 7.6 132 63-243
50+ 6 5.7 105 38-228
both studies. Only other myeloid leukemia in the refinery
study shows markedly increased mortality (asjudged by
the confidence interval). Monocytic leukemia in the refin-
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Table 6. Observed (0) and expected (E) deaths, standardized mortality ratio (SMR),
and 95% confidence intervals (CI) for total study population for leukemias by type.
Refinery study Distribution study
Disease group 0 E SMR 95% CI 0 E SMR 95% CI
Acute lymphatic 4 5.3 75 20-192 5 3.8 133 43-309
Chronic lymphatic 12 15.8 76 39-133 16 13.9 115 66-187
Other lymphatic 2 0.67 301 36-1086 0 0.57 0 0-646
All lymphatic 18 21.8 83 48-131 21 18.3 115 71-176
Acute myeloid 20 26.6 73 46-116 25 20.6 121 78-179
Chronic myeloid 11 12.3 89 45-160 8 9.7 82 36-162
Other myeloid 7 1.0 678 273-1397 1 0.89 113 3-629
All myeloid 38 40.0 95 63-125 34 31.2 109 75-152
All monocytic 7 3.2 221 89-455 2 2.6 77 9-279
Other leukemia 5 5.2 97 31-225 4 4.3 93 25-239
Total leukemia 68 69.8 97 76-124 61 56.4 108 83-140
ery study and acute myeloid in the distribution center
studyareincreased to alesserextent. Thereis atendency
for the mortality from all leukemia to increase with
increased time since first exposure in the distribution
center study, but there is no clear pattern in the refinery
study.
Only one refinery shows increased mortality from leu-
kemia, namely, refinery D, where there are 14 observed
deaths from leukemia (E = 8.6, SMR = 164, 95% CI, 89-
275). Twelve of these are myeloid leukemias (E = 4.98,
SMR = 241,95% CI, 124-421). Thisrefinery shows excess
mortality for acute myeloid leukemia (O = 7, E = 3.3,
SMR = 210,95% CI, 84-433) and othermyeloid leukemia
(O = 2, E = 0.1, SMR = 1621,95%CI, 196-5854).Twenty-
one ofthe 68refinery leukemia deaths are in operators (E
= 17.3, SMR = 123, 95% CI, 75-186) and 6 out of the 7
other myeloid leukemias are in operators.
In the distribution center study, increased mortality is
found in company 2 for lymphatic leukemia, in particular,
chroniclymphatic leukemia(O=15, E = 8.52, SMR = 176,
95% CI, 99-290) and to a much lesser extent in acute
myeloidleukemia (O = 17, E = 13.15, SMR = 129,95% CI,
75-207). Twenty-two of the 46 deaths from all leukemia
from company2 startedworkbefore 1940 (E = 14.1, SMR
= 156, 95% CI, 98-236).
Table 7 gives the observed and expected deaths, SMRs,
and 95% confidence intervals by type of leukemia for
drivers. Mortality from all leukemia is raised in the total
distribution center study population and, in particular, at
company 2 (O = 21, E = 14.6, SMR = 133, 95% CI, 89-
220). Nineteen of the leukemia deaths in drivers are
myeloid, with thirteen being acute myeloid.
There are also 15 otherdeaths intherefinerystudyand
12 in the distribution center study where leukemia is a
contributory cause of death, 17 of these being chronic
lymphatic leukemias.
Discussion
In both the studies, over 99% of the population was
successfully traced. Death certificates were obtained for
all but 0.7% of the deaths. Before commenting on the
results obtained in this study, it is appropriate to indicate
Table 7. Observed (0) and expected (E) deaths, standardized
mortality ratio (SMR), and 95% confidence intervals (CI)
for leukemia in drivers.
lrpe 0 E SMR 95% CI
All lymphatic 4 7.02 57 16-146
Acute myeloid 13 8.39 155 82-265
Chronic myeloid 5 3.94 127 41-296
Other myeloid 1 0.34 293 7-1634
Total myeloid 19 12.68 150 90-234
All monocytic 2 1.01 198 24-715
All other leukemia 3 1.69 78 37-319
Total leukemia 28 22.40 125 83-181
briefly some ofthelimitations ofthis type ofcohortstudy,
the problems inherent in interpreting the results, and
outline some of the possible causes of variation in mor-
tality. Theseincludeinaccuracyindiagnosis, classification
andcodingofthecausesofdeath, andomissionofinforma-
tion from the death certificates.
The SMR (and its confidence interval) has beenused in
this study to describe the patterns of mortality and to
search for consistency across variables and subgroups
examined. The interpretation of subgroup analyses when
the all-cause mortality is low, and the impact of the
reanalysis ofdata in a cohort study after an additional 14
years follow-up needs to be considered. Differences in the
workforceortypeofworkplacebetweentherefineriesand
the three distribution center companies may partly
account for noncomparability in the mortality patterns.
Thelarge size ofthecohortwasthereasonthatonlythe
last job title for leavers (or current title for those in
employment on December 31, 1975) could be collected to
define occupational group. In addition, no lifestyle infor-
mation, suchas dataonsmokingandalcohol,wascollected
so thatcaution is necessarywheninterpretingtheresults.
The overall relative mortality of the two study popula-
tionsremainslow,continuingtoexhibitthehealthyworker
effect. This lowered mortality is also reflected in many of
the numericallylarge, nonmalignant causes ofdeath such
as cerebrovascular disease, pneumonia, and bronchitis.
Some ofthe individualjob groups show slightlyincreased
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mortality from specific nonmalignant disease groups, in
particular, stroke and heart disease in laborers/general
manualworkers inboth studies, andbronchitis in security
men in the distribution center study. However, this mor-
tality is, in general, not greater than that of men of a
similarsocial statusinthemalepopulationofEngland and
Wales.
The consistently raised mortality from diseases ofthe
arteries in the refinery study and from ischemic heart
disease inthe distribution center studyis more difficult to
interpret, being high across several age and job groups.
The patterns forthese diseases are in contrast to those of
most of the heart disease groups, where the mortality is
generally low.
Mortality from all neoplasms in both studies is lower
than expected, duemainlytomarked deficits inmalignant
neoplasm of the lung. It has been suggested that oil
industry employees may smoke somewhat less than the
general population (66) and that there is unlikely to be
serious confounding of the results due to smoking in
studies where this information is not available (67).
As discussed previously, concern has been expressed
about increased mortality from such diseases as malig-
nant diseases oftheprostate, kidney, andbrain; leukemia;
and otherlymphatic neoplasms (22,37,38,68). Inbothstud-
ies, the slightly increased mortality from malignant neo-
plasm of the prostate continues in the second follow-up
period, with operators again having markedly increased
mortality. There are no increased mortalitypatterns from
malignant neoplasm ofthe brain in either study.
Therewerenoincreasedmortalitypatternsfrommalig-
nantneoplasmofthekidneyintherefinerystudy.Areview
of the epidemiological evidence from 11 refinery studies
(38) suggested that, although they were not generally
supportive of an association between kidney cancer and
gasoline,therewas someevidence ofasmallkidneycancer
excess among older workers, or among workers exposed
for long periods. Mortality from malignant neoplasm of
the kidney is increased overall in the present distribution
center study and in drivers in particular. There is a
tendency for the mortality to increase with increasing
time since first exposure.
Particular interest has been paid to mortality from
leukemia and its possible relation with exposure to ben-
zene and other solvents (28,30). The total observed deaths
from leukemia in both studies are once again similar to
those expected. Markedly increased mortality is found in
onlyonerefinery, andfrommyeloidleukemiainparticular.
Just less than one-third of the leukemia deaths in the
refinery study are in operators. In the distribution center
study, markedly increased mortality is found in only one
company. Nearlyhalfoftheleukemiadeathsareindrivers,
andmortalityisincreasedfordriversformyeloidleukemias,
and in particular acute myeloid leukemia. A nested case-
control study carried out on the leukemia deaths after the
first follow-up period in the refinery studyfound the risk of
leukemia in thosewith high ormediumexposure to benzene
to be twice that ofthose with low exposure (69).
Although the contributory causes ofdeath on the death
certificates were coded and entered into the database, no
detailed analyses of these have so far been carried out.
However, the deaths with a malignant neoplasm as a
contributory cause were investigated. The ratio of the
numberoftotalmentions ofeachmalignantneoplasm over
the number ofunderlying causes ofthat disease group in
the study population was compared to the ratios from the
population ofEngland andWales (70) and generallyfound
to be similar. The ratios for malignant neoplasms of the
kidneyandbladderforthe distribution center studypopu-
lation are higher than those ofEngland and Wales, which
may suggest a possible underreporting ofthese diseases
as the underlying cause of death (71) and may perhaps
strengthenconcernaboutincreasedmortalityfrommalig-
nant neoplasm ofthe kidney.
The specific issues of concern reported here can be
further examined using nested case-control studies.
Deaths from leukemia and malignant neoplasm of the
kidneycouldbe matched to controls selectedfromthe rest
ofthestudypopulation. Furtherdetailssuchasjobhistory
or exposure to potential hazards can then be efficiently
obtained for the limited number ofcases and controls.
ThedataforthisstudywerehandledbyLindaMcFadyen. Thefunding
came from the Institute of Petroleum. I thank the IP Working Party
under the chairmanship of Charles Binns and Mark Cross and other
membersoftheDepartmentofMathematics,Statistics andComputingat
Thames Polytechnic for theirhelp and advice onthe study. I am grateful
to OPCS, the DSS, and the Registrar General for Scotland for carrying
outthe flagging and tracing ofthe studypopulation. The keyrole played
by the late Michael Alderson in both follow-ups is acknowledged.
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